May 2026 exceptional surveillance of anaphylaxis: assessment and referral after emergency treatment (NICE guideline CG134)
Methods
This exceptional surveillance process consisted of:
-
Identifying inconsistencies between NICE's guideline on anaphylaxis and the RCUK's guideline and where the content overlaps.
-
Considering the evidence used to develop NICE's guideline on anaphylaxis and the RCUK's guideline.
-
Assessing the new evidence against current recommendations to determine whether or not to update sections of the guideline, or the whole guideline.
-
Consulting with NICE's Consultant Clinical Advisers (CCAs).
-
Consulting with topic experts from NICE's expert adviser's database about the proposals.
For further details about the process and the possible update decisions that are available, see ensuring that published guidelines are current and accurate in developing NICE guidelines: the manual.
This page was last updated: